- Home
- CLDI vs LUCY Comparison
CLDI vs LUCY Comparison
Compare CLDI & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- LUCY
- Stock Information
- Founded
- CLDI 2014
- LUCY 2017
- Country
- CLDI United States
- LUCY United States
- Employees
- CLDI N/A
- LUCY N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- LUCY Ophthalmic Goods
- Sector
- CLDI Health Care
- LUCY Health Care
- Exchange
- CLDI Nasdaq
- LUCY Nasdaq
- Market Cap
- CLDI 8.7M
- LUCY 8.7M
- IPO Year
- CLDI N/A
- LUCY 2022
- Fundamental
- Price
- CLDI $1.60
- LUCY $1.97
- Analyst Decision
- CLDI
- LUCY
- Analyst Count
- CLDI 0
- LUCY 0
- Target Price
- CLDI N/A
- LUCY N/A
- AVG Volume (30 Days)
- CLDI 141.6K
- LUCY 716.5K
- Earning Date
- CLDI 11-11-2025
- LUCY 11-11-2025
- Dividend Yield
- CLDI N/A
- LUCY N/A
- EPS Growth
- CLDI N/A
- LUCY N/A
- EPS
- CLDI N/A
- LUCY N/A
- Revenue
- CLDI N/A
- LUCY $1,978,018.00
- Revenue This Year
- CLDI N/A
- LUCY $149.32
- Revenue Next Year
- CLDI N/A
- LUCY $400.00
- P/E Ratio
- CLDI N/A
- LUCY N/A
- Revenue Growth
- CLDI N/A
- LUCY 29.30
- 52 Week Low
- CLDI $1.41
- LUCY $1.57
- 52 Week High
- CLDI $46.68
- LUCY $10.40
- Technical
- Relative Strength Index (RSI)
- CLDI 43.90
- LUCY 49.45
- Support Level
- CLDI $1.41
- LUCY $1.90
- Resistance Level
- CLDI $1.68
- LUCY $2.08
- Average True Range (ATR)
- CLDI 0.08
- LUCY 0.12
- MACD
- CLDI 0.05
- LUCY 0.00
- Stochastic Oscillator
- CLDI 66.74
- LUCY 25.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.